Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian G Wicha

Showing results (71-80 of 116) with videos related to

Pageof 12
Sort By:
Microorganisms|October 23, 2021
Voriconazole Pharmacokinetics Are Not Altered in Critically Ill Patients with Acute-on-Chronic Liver Failure and Continuous Renal Replacement Therapy: An Observational StudyJörn Grensemann, Christoph Pfaffendorf, Sebastian G Wicha, et al.
Clinical Pharmacology and Therapeutics|February 10, 2021
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for AntibioticsSebastian G Wicha, Anne-Grete Märtson, Elisabet I Nielsen, et al.
International Journal of Antimicrobial Agents|September 22, 2021
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelinesCindy Lau, Deborah Marriott, Hayley B Schultz, et al.
International Journal of Antimicrobial Agents|March 28, 2022
Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK modelsAstrid Heus, David W Uster, Veerle Grootaert, et al.
Annals of Intensive Care|May 29, 2026
Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failureEmily Behrens, Christina König, Dominik Jarczak, et al.
Clinical Pharmacokinetics|December 5, 2022
Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood LevelsValentin Al Jalali, Martin Bauer, Michael Wölfl-Duchek, et al.
Journal of Clinical Pharmacology|May 22, 2019
Is Moxifloxacin a Treatment Option for Pancreatic Infections? A Pharmacometric Analysis of Serum and Pancreatic JuiceSebastian G Wicha, Ralf G Mundkowski, Andrea Klock, et al.
Therapeutic Drug Monitoring|September 16, 2016
Variable Linezolid Exposure in Intensive Care Unit Patients-Possible Role of Drug-Drug InteractionsChristoph Töpper, Cathérine L Steinbach, Christoph Dorn, et al.
Malaria Journal|March 20, 2026
Population pharmacokinetics of fosmidomycin and clindamycin in combination with artesunate for uncomplicated Plasmodium falciparum malaria in Gabonese children and adultsChristoph Pfaffendorf, Jean Claude Dejon-Agobé, Jean Ronald Edoa, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2022
New <i>In Vitro</i> Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial CombinationsSebastian G Wicha, Annabelle Walz, Mohammed H Cherkaoui-Rbati, et al.
Pageof 12

Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Microorganisms|October 23, 2021
Voriconazole Pharmacokinetics Are Not Altered in Critically Ill Patients with Acute-on-Chronic Liver Failure and Continuous Renal Replacement Therapy: An Observational StudyJörn Grensemann, Christoph Pfaffendorf, Sebastian G Wicha, et al.
Clinical Pharmacology and Therapeutics|February 10, 2021
From Therapeutic Drug Monitoring to Model-Informed Precision Dosing for AntibioticsSebastian G Wicha, Anne-Grete Märtson, Elisabet I Nielsen, et al.
International Journal of Antimicrobial Agents|September 22, 2021
Assessment of cefepime toxicodynamics: comprehensive examination of pharmacokinetic/pharmacodynamic targets for cefepime-induced neurotoxicity and evaluation of current dosing guidelinesCindy Lau, Deborah Marriott, Hayley B Schultz, et al.
International Journal of Antimicrobial Agents|March 28, 2022
Model-informed precision dosing of vancomycin via continuous infusion: a clinical fit-for-purpose evaluation of published PK modelsAstrid Heus, David W Uster, Veerle Grootaert, et al.
Annals of Intensive Care|May 29, 2026
Prospective study of pharmacokinetics of isavuconazole in critically ill patients undergoing continuous hemodialysis with and without acute-on-chronic liver failureEmily Behrens, Christina König, Dominik Jarczak, et al.
Clinical Pharmacokinetics|December 5, 2022
Pilot Pharmacokinetic Study in Healthy Adults Using Intravascular Microdialysis Catheters Modified for Use in Paediatric Patients to Assess Vancomycin Blood LevelsValentin Al Jalali, Martin Bauer, Michael Wölfl-Duchek, et al.
Journal of Clinical Pharmacology|May 22, 2019
Is Moxifloxacin a Treatment Option for Pancreatic Infections? A Pharmacometric Analysis of Serum and Pancreatic JuiceSebastian G Wicha, Ralf G Mundkowski, Andrea Klock, et al.
Therapeutic Drug Monitoring|September 16, 2016
Variable Linezolid Exposure in Intensive Care Unit Patients-Possible Role of Drug-Drug InteractionsChristoph Töpper, Cathérine L Steinbach, Christoph Dorn, et al.
Malaria Journal|March 20, 2026
Population pharmacokinetics of fosmidomycin and clindamycin in combination with artesunate for uncomplicated Plasmodium falciparum malaria in Gabonese children and adultsChristoph Pfaffendorf, Jean Claude Dejon-Agobé, Jean Ronald Edoa, et al.
Antimicrobial Agents and Chemotherapy|October 5, 2022
New <i>In Vitro</i> Interaction-Parasite Reduction Ratio Assay for Early Derisk in Clinical Development of Antimalarial CombinationsSebastian G Wicha, Annabelle Walz, Mohammed H Cherkaoui-Rbati, et al.
Pageof 12